New Therapies for the Treatment of Inflammatory Bowel Disease

Bruce E. Sands

doi:10.1016/j.suc.2006.05.009

New Therapies for the Treatment of Inflammatory Bowel Disease

Bruce E. Sands

Research output: Contribution to journal › Review article › peer-review

14 Scopus citations

Abstract

Medical therapy of IBD has made remarkable progress in recent years, driven forward by new knowledge about mechanisms of disease and advances in biotechnology. As we continue to learn about how best to use the agents currently in our hands, the addition of new drugs will further improve outcomes, and will bring new insights into the fundamental causes of these diseases.

Original language	English
Pages (from-to)	1045-1064
Number of pages	20
Journal	Surgical Clinics of North America
Volume	86
Issue number	4
DOIs	https://doi.org/10.1016/j.suc.2006.05.009
State	Published - Aug 2006
Externally published	Yes

Access to Document

10.1016/j.suc.2006.05.009

Cite this

@article{1c42e29b467442c99ed3a5e07ac5a407,

title = "New Therapies for the Treatment of Inflammatory Bowel Disease",

abstract = "Medical therapy of IBD has made remarkable progress in recent years, driven forward by new knowledge about mechanisms of disease and advances in biotechnology. As we continue to learn about how best to use the agents currently in our hands, the addition of new drugs will further improve outcomes, and will bring new insights into the fundamental causes of these diseases.",

author = "Sands, {Bruce E.}",

year = "2006",

month = aug,

doi = "10.1016/j.suc.2006.05.009",

language = "English",

volume = "86",

pages = "1045--1064",

journal = "Surgical Clinics of North America",

issn = "0039-6109",

publisher = "W.B. Saunders Ltd",

number = "4",

}

TY - JOUR

T1 - New Therapies for the Treatment of Inflammatory Bowel Disease

AU - Sands, Bruce E.

PY - 2006/8

Y1 - 2006/8

N2 - Medical therapy of IBD has made remarkable progress in recent years, driven forward by new knowledge about mechanisms of disease and advances in biotechnology. As we continue to learn about how best to use the agents currently in our hands, the addition of new drugs will further improve outcomes, and will bring new insights into the fundamental causes of these diseases.

AB - Medical therapy of IBD has made remarkable progress in recent years, driven forward by new knowledge about mechanisms of disease and advances in biotechnology. As we continue to learn about how best to use the agents currently in our hands, the addition of new drugs will further improve outcomes, and will bring new insights into the fundamental causes of these diseases.

UR - http://www.scopus.com/inward/record.url?scp=33746894599&partnerID=8YFLogxK

U2 - 10.1016/j.suc.2006.05.009

DO - 10.1016/j.suc.2006.05.009

M3 - Review article

C2 - 16905423

AN - SCOPUS:33746894599

SN - 0039-6109

VL - 86

SP - 1045

EP - 1064

JO - Surgical Clinics of North America

JF - Surgical Clinics of North America

IS - 4

ER -

New Therapies for the Treatment of Inflammatory Bowel Disease

Abstract

Access to Document

Fingerprint

Cite this